GM&C Life Sciences Fund

The GM&C Life Sciences Fund is a seed and early-stage venture capital fund based in the United Kingdom's Greater Manchester and Cheshire & Warrington region that invests in biotechnology, pharmaceuticals, and healthcare startups. Operating as a public-sector backed investment vehicle, the firm launched with £31 million in capital and typically writes initial checks ranging from £100,000 to £1,500,000. Managed by Catapult Ventures, the fund acts as both a lead and follow-on investor, having deployed capital into 42 companies across the medical device, diagnostic, and digital health sectors by mid-2021. The firm's active portfolio includes digital healthcare and life sciences companies such as Rinicare and Clin-e-cal, supported by strategic partnerships with organizations like Manchester Science Partnerships. The fund was established in October 2015 through a joint collaboration between the Greater Manchester Combined Authority and Cheshire East Council.